Viridian Therapeutics (0K1R) Short Interest
LSE • 0K1R • US92790C1045
As of Oct 22, 2026, ORTEX estimated 1.8% of free float sold short, 1,292.5 days to cover, cost to borrow 0.52%. Sign up for live short interest data.
LSE • 0K1R • US92790C1045
As of Oct 22, 2026, ORTEX estimated 1.8% of free float sold short, 1,292.5 days to cover, cost to borrow 0.52%. Sign up for live short interest data.
This page tracks how heavily Viridian Therapeutics (LSE:0K1R) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Viridian Therapeutics (LSE: 0K1R) has a market capitalization of $3.23B. Last close $29.03 (as of 2026-11-09); 52-week range $13.25 to $34.31. ORTEX data as of 2026-10-22: short interest was 1.77% of free float, 1,292.5 days to cover and the average cost to borrow was 0.52%. Sign up for live short interest data.